Morepen Laboratories Limited has informed the Exchange regarding disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015''.
MOREPENLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Morepen Laboratories had received a Show Cause Notice (SCN) from the Central GST & Central Excise Commissionerate, Shimla, alleging that the company had wrongly claimed an excess GST refund of about ₹117.94 crore under Section 54 of the CGST Act, 2017 read with Rule 89 of the CGST Rules. The company challenged this notice by filing a writ petition before the Himachal Pradesh High Court at Shimla. The High Court, through its order dated 6th January 2026, has allowed the petition and granted a stay on the operation of the SCN. The company has stated that, in view of the stay, there is no impact on its financials, operations, or other activities at present. The underlying tax matter, however, remains pending and is yet to be finally resolved.
Short-term relief for shareholders as the immediate enforcement risk on the ~₹117.94 crore demand is paused, which may support sentiment on the stock. However, the matter is still alive in court and a future adverse outcome could create a significant financial liability, so the risk has only been deferred, not eliminated.